ExpreS2ion Biotech Holding AB (5JD0) AI Stock Analysis

2 Followers

ExpreS2ion Biotech Holding AB

(Frankfurt:5JD0)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Proprietary protein platformThe proprietary expression platform addresses technically difficult proteins used in vaccines and diagnostics, which can support differentiated expertise and customer value. Its application across pharmaceutical, biotechnology, and academic customers provides a foundation for recurring commercial opportunities over the medium term.

Negative Factors

Persistent unprofitable operationsNegative gross profit and large operating losses show that current revenue does not cover the cost base, limiting evidence of an economically scalable model. Continued losses can constrain investment capacity and make future progress dependent on achieving materially stronger revenue economics.

ExpreS2ion Biotech Holding AB (5JD0) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 3.36M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -0.1
Beta (1Y): 3.55
Revenue Growth: 0.63%
EPS Growth: 54.08%
Country: Germany
Employees: 19
Sector: Healthcare
Sector Strength: 51
Industry: Biotechnology

ExpreS2ion Biotech Holding AB Business Overview & Revenue Model

Company Description

Based in Horsholm, Denmark, ExpreS2ion Biotech Holding AB, along with its subsidiary ExpreS2ion Biotechnologies, specializes in creating and manufacturing complex proteins for use in vaccines and diagnostic products. The company's development pipelin...

ExpreS2ion Biotech Holding AB Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:5JD0 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SE:CANTA	83Outperform	SEK 415.59M	2.10	63.09%	―	―	―
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
SE:IVACC	46Neutral	SEK 264.47M	-2.97	-34.25%	―	-0.71%	54.16%
SE:BINV	43Neutral	SEK 201.36M	-0.41	-128.54%	―	-83.67%	-50.29%
SE:IMMU	43Neutral	SEK 315.58M	-2.74	-18.05%	―	―	13.06%
SE:XBRANE	43Neutral	SEK 256.54M	-6.67	-11.52%	―	-38.80%	-120.18%

* Healthcare Sector Average

Performance Comparison

DE:5JD0 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:5JD0	ExpreS2ion Biotech Holding AB	0.06	-0.52	-90.43%
SE:BINV	BioInvent International AB	3.02	-27.13	-89.98%
SE:XBRANE	Xbrane Biopharma AB	12.05	1.94	19.19%
SE:IVACC	Intervacc AB	0.79	-0.12	-12.94%
SE:IMMU	Immunicum AB	4.90	-0.89	-15.37%
SE:CANTA	Cantargia AB	1.43	-2.16	-60.17%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

ExpreS2ion Biotech Holding AB AI Stock Analysis